Nicholas Cardoso,Chong-Hui Gu,Peter A. Ojakovo,Tapan Sanghvi,Eric A. Simone,Marinus J. Verwijs
申请号：
US14163064
公开号：
US20140235705A1
申请日:
2014.01.24
申请国别(地区):
US
年份:
2014
代理人:
摘要：
A pharmaceutical composition comprises: a) polymorphic form M or tromethamine salt of Compound (1) represented by the following structural formula:and b) a filler. A method of preparing a pharmaceutical composition comprises: providing a mixture of Compound (1) and a filler to form the composition of Compound (1). A method of treating a HCV infection in a subject comprises administering to the subject a therapeutically effective amount of the pharmaceutical composition.
